Population
Humans
Comparison
Intravenous bolus infusion of ex vivo-labeled… vs In vivo-labeled VLDL-TG
Design
Other
Authors
Loading...
May enable VLDL-TG turnover studies without precursor pools; leaves open prospective validation before research adoption.
The described ex vivo labeling method provides a robust approach for measuring VLDL-triglyceride turnover and tissue uptake in humans without confounding from labeled FFA precursor pools.
Gormsen et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: